RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+1.25%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$1.99B
AUM Growth
+$1.99B
(+4.3%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
6.57%
Top 10 Holdings %
Top 10 Hldgs %
40.54%
Holding
101
New
13
Increased
27
Reduced
12
Closed
14
Top Buys
| 1 |
Mativ Holdings
MATV
|
$54.2M |
| 2 |
DEN
Denbury Inc.
DEN
|
$48.2M |
| 3 |
Noble Corp
NE
|
$43M |
| 4 |
Green Plains
GPRE
|
$29.8M |
| 5 |
Valaris
VAL
|
$28.2M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$72.2M |
| 2 |
Greif
GEF
|
$37.4M |
| 3 |
Insmed
INSM
|
$25.4M |
| 4 |
BRSL
Brightstar Lottery PLC
BRSL
|
$23.9M |
| 5 |
IEA
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
|
$22.6M |
Sector Composition
| 1 | Healthcare | 23.08% |
| 2 | Industrials | 19.95% |
| 3 | Energy | 18.9% |
| 4 | Financials | 10.05% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
EverQuote
EVER
$841M
| $8.5M | 0.43% |
1,246,622
-229,123
| -16% | -$1.56M |
|
52
Ovid Therapeutics
OVID
$94.6M
| $8.31M | 0.42% |
4,516,300
+1,633,594
| +57% | +$3.01M |
|
53
Sutro Biopharma
STRO
$85.6M
| $7.77M | 0.39% |
1,400,000
+500,000
| +56% | +$2.78M |
|
54
TherapeuticsMD
TXMD
$12.7M
| $7.68M | 0.39% |
1,156,953
+365,122
| +46% | +$2.42M |
|
55
FTAI Infrastructure
FIP
$479M
| $7.66M | 0.39% |
+3,193,530
| New | +$7.66M |
|
56
Nerdy
NRDY
$159M
| $7.28M | 0.37% |
3,450,406
| – | – |
|
57
Cullinan Oncology
CGEM
$456M
| $7.18M | 0.36% |
559,737
+262,390
| +88% | +$3.36M |
|
58
Laureate Education
LAUR
$4.12B
| $6.92M | 0.35% |
+655,482
| New | +$6.92M |
|
59
PLAYSTUDIOS Inc
MYPS
$118M
| $6.85M | 0.34% |
1,961,184
| – | – |
|
60
Krystal Biotech
KRYS
$4.35B
| $6.46M | 0.33% |
92,609
| – | – |
|
61
89bio
ETNB
$1.37B
| $5.73M | 0.29% |
+989,388
| New | +$5.73M |
|
62
Tarsus Pharmaceuticals
TARS
$2.44B
| $4.88M | 0.25% |
284,732
+82,084
| +41% | +$1.41M |
|
63
ATAI Life Sciences
ATAI
$969M
| $4.37M | 0.22% |
1,319,137
| – | – |
|
64
Werewolf Therapeutics
HOWL
$62.6M
| $4.36M | 0.22% |
966,879
+761,883
| +372% | +$3.44M |
|
65
MediaAlpha
MAX
$613M
| $4.26M | 0.21% |
486,910
-147,669
| -23% | -$1.29M |
|
|
VIRX
66
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.25M | 0.21% |
+994,801
| New | +$4.25M |
|
67
AvePoint
AVPT
$3.41B
| $4.08M | 0.21% |
1,017,539
-2,212,626
| -68% | -$8.87M |
|
68
Advantage Solutions
ADV
$551M
| $4.03M | 0.2% |
1,889,574
| – | – |
|
|
TSVT
69
DELISTED
2seventy bio
TSVT
| $3.86M | 0.19% |
265,000
| – | – |
|
70
Theravance Biopharma
TBPH
$691M
| $3.61M | 0.18% |
+356,100
| New | +$3.61M |
|
71
Xoma
XOMA
$421M
| $3.6M | 0.18% |
200,785
+51,339
| +34% | +$919K |
|
72
CytomX Therapeutics
CTMX
$350M
| $3.49M | 0.18% |
2,406,449
| – | – |
|
73
Precision BioSciences
DTIL
$59.5M
| $3.45M | 0.17% |
2,657,115
| – | – |
|
|
VINC
74
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.91M | 0.15% |
2,107,000
| – | – |
|
|
TVRD
75
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $2.5M | 0.13% |
266,966
| – | – |
|